Product NDC: | 13668-141 |
Proprietary Name: | Clopidogrel Bisulfate |
Non Proprietary Name: | Clopidogrel Bisulfate |
Active Ingredient(s): | 75 mg/1 & nbsp; Clopidogrel Bisulfate |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 13668-141 |
Labeler Name: | Torrent Pharmaceuticals Limited |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA090844 |
Marketing Category: | ANDA |
Start Marketing Date: | 20120517 |
Package NDC: | 13668-141-30 |
Package Description: | 30 TABLET in 1 BOTTLE (13668-141-30) |
NDC Code | 13668-141-30 |
Proprietary Name | Clopidogrel Bisulfate |
Package Description | 30 TABLET in 1 BOTTLE (13668-141-30) |
Product NDC | 13668-141 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Clopidogrel Bisulfate |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20120517 |
Marketing Category Name | ANDA |
Labeler Name | Torrent Pharmaceuticals Limited |
Substance Name | CLOPIDOGREL BISULFATE |
Strength Number | 75 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Decreased Platelet Aggregation [PE],P2Y12 Platelet Inhibitor [EPC],P2Y12 Receptor Antagonists [MoA] |